Take a look behind the scenes of a recent Future Microbiology review as we ask the authors about quorum quenching and using nanoparticles as antibiotics.
Take a look behind the scenes of a recent Future Microbiology paper as we ask the authors about the challenges in treating respiratory tract infections and how nanomedicines could help.
Researchers have pioneered novel, gold nanoparticles, which bind and deform viruses rendering them inactive, thereby presenting potential in the development of a broad-spectrum antiviral.
Green synthesis of capped gold nanoparticles and their effect on Gram-positive and Gram-negative bacteria
This research reports the synthesis of capped gold nanoparticles by reducing HAuCl4 with flower and leaf extracts of Ocimum tenuiflorum, leaves of Azadirachta indica and Mentha spicata and peel of Citrus sinensis plants and assessed their activity on Staphylococcus aureus, Pseudomonas aeruginosa and Klebsiella pneumoniae.
Despite significant advances in the treatment of human immunodeficiency virus (HIV), there remain challenges. This review highlights recent advances in the application of nanotechnology to drug delivery, specifically with the purpose of improving HIV therapy.
Silver nanoparticles have long been used as potent antibacterial agents. However, toxicity concerns of silver nanoparticles have limited their successful clinical applications. This research reports a simple and cost-effective method for the synthesis of nickel-prussian blue@silver nanocomposites.
Researchers from Washington University of St. Louis have developed a proof-of-concept test that can rapidly detect the presence of Zika virus in blood, without the need for refrigeration.
Researchers have uncovered a therapeutic delivery method for nitric oxide in the treatment of dermal Trichophyton rubrum dermatophytosis; providing an alternative treatment to the systemic therapies currently used.
In this exclusive piece the authors discuss the choice of peptide antigen, delivery system/adjuvant and delivery route as key factors in the development of an effective human vaccine against group A Streptococcus.
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice
Development of protein vaccine to prevent congenital infection is a public health priority, this research investigates the design of a mucosal synthetic pathogen as a vaccine strategy against congenital toxoplasmosis.